Radiation Medicine Rounds - Volume 3 Issue 3 - Hematologic Malignancies

Michael B Tomblin and others ("Guest Editors")

ISBN 10: 1936287773 / ISBN 13: 9781936287772

Published by DemosMedical, NY, 2012

About this Item

160 pages ([xiv, 367-536), coloured and half-tone illustrations, index; publisher's navy-blue laminated covers. Issued without dust-jacket. New book. Pictures show this actual book. UK orders are post-free.

Seller Inventory # 152145

Bibliographic Details

• Title: Radiation Medicine Rounds - Volume 3 Issue 3 - Hematologic Malignancies
• Publisher: DemosMedical, NY
• Publication Date: 2012
• Language: English
• ISBN 10: 1936287773
• ISBN 13: 9781936287772
• Binding: Hardcover/Hardback
• Edition: First edition.
• Condition: New
• Dust Jacket Condition: No Jacket
• Seller catalogs:
  • Academic Books
  • Science, Engineering, Mathematics &c.

About this title

Synopsis

Radiation Medicine Rounds is a trinary hard cover periodical designed to provide an up-to- date review of a dedicated radiation medicine topic of interest to clinicians and scientists who are involved in the care of patients receiving radiotherapy. It is intended to serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinicians, medical physicists, cancer biologists, radiobiologists, and interdisciplinary colleagues throughout the oncology spectrum.

This issue of Radiation Medicine Rounds discusses the more salient topics surrounding the role of radiation therapy for hematologic malignancies. There are literally dozens of distinct lymphoma subtypes, each with its own unique molecular and clinical features. Although systemic cytotoxic and targeted therapies have improved dramatically, radiation therapy remains an important modality for optimal clinical outcomes. With contributions from nationally recognized experts, Hematologic Malignancies offers an overview of the full spectrum of therapy for hematologic malignancies ranging from lymphoma and leukemia to plasma cell dyscrasias. Recent advances in radiotherapy for hematologic malignancies allow for maintenance of excellent local control with improvements in toxicity achieved through reductions in field sizes, in dose delivered, and increasingly conformal delivery techniques. Hematologic Malignancies provides the practitioner with a current overview of best practices, recent research, and future directions in the management of these complex cancers.

"

About the Authors

Michael Tomblyn, MD, MS, Assistant Member Radiation Oncology Moffitt Cancer Center & Research Institute, Tampa FL

Karen Winkfield, MD, PhD, Hematologic Malignancy Service, Department of Radiation Oncology, Massachusetts General Hospital

Bouthaina S. Dabaja, MD, Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Charles R. Thomas, Jr., MD is Professor and Chairman of the Department of Radiation Medicine and Professor of Hematology/Oncology at the Oregon Health & Science University Cancer Institute.